nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—TACR1—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.00752	0.00763	CbGpPWpGaD
Ketamine—TACR1—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.00743	0.00753	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.0073	0.0074	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—P2RY12—abdominal aortic aneurysm	0.00723	0.00733	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00708	0.00718	CbGpPWpGaD
Ketamine—GRIN1—EPH-Ephrin signaling—MMP2—abdominal aortic aneurysm	0.00705	0.00714	CbGpPWpGaD
Ketamine—GRIN2B—EPH-Ephrin signaling—MMP2—abdominal aortic aneurysm	0.00687	0.00696	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.00685	0.00694	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.00673	0.00682	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.00671	0.0068	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.00655	0.00664	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.0064	0.00649	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.00617	0.00626	CbGpPWpGaD
Ketamine—TACR1—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.00612	0.0062	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—P2RY12—abdominal aortic aneurysm	0.00611	0.00619	CbGpPWpGaD
Ketamine—OPRD1—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.00595	0.00603	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.00575	0.00583	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.00572	0.0058	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.00567	0.00575	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00557	0.00565	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00539	0.00547	CbGpPWpGaD
Ketamine—GRIN1—EPH-Ephrin signaling—MMP9—abdominal aortic aneurysm	0.0053	0.00537	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.00521	0.00528	CbGpPWpGaD
Ketamine—GRIN2B—EPH-Ephrin signaling—MMP9—abdominal aortic aneurysm	0.00516	0.00523	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.00507	0.00514	CbGpPWpGaD
Ketamine—PTGS1—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00505	0.00512	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.00503	0.0051	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00501	0.00508	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00499	0.00506	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00498	0.00505	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.00486	0.00492	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00465	0.00472	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—P2RY12—abdominal aortic aneurysm	0.00463	0.00469	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00455	0.00461	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.00442	0.00448	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.00441	0.00447	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00438	0.00444	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.0043	0.00435	CbGpPWpGaD
Ketamine—OPRD1—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.00418	0.00424	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.00417	0.00423	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.0041	0.00416	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00408	0.00414	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00399	0.00404	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.00394	0.00399	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00379	0.00385	CbGpPWpGaD
Ketamine—GRIN1—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.00373	0.00378	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.0037	0.00375	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.00368	0.00373	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.00368	0.00373	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.00367	0.00372	CbGpPWpGaD
Ketamine—GRIN2B—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.00363	0.00368	CbGpPWpGaD
Ketamine—OPRD1—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00353	0.00358	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.0035	0.00354	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.00349	0.00354	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00345	0.0035	CbGpPWpGaD
Ketamine—OPRD1—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.00345	0.00349	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00328	0.00333	CbGpPWpGaD
Ketamine—CYP2C8—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00326	0.00331	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.00321	0.00326	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00312	0.00317	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.0031	0.00314	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00309	0.00314	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	0.00309	0.00314	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00305	0.00309	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00304	0.00308	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.00302	0.00306	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00296	0.003	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00287	0.00291	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00283	0.00287	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00282	0.00286	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00281	0.00284	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.0028	0.00284	CbGpPWpGaD
Ketamine—PTGS1—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.00279	0.00283	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00277	0.0028	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00269	0.00272	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00266	0.0027	CbGpPWpGaD
Ketamine—CYP2C9—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00265	0.00269	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MMP2—abdominal aortic aneurysm	0.00262	0.00265	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00262	0.00265	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00261	0.00265	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.00261	0.00264	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00256	0.0026	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.00255	0.00259	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MMP2—abdominal aortic aneurysm	0.00255	0.00259	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00247	0.00251	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00247	0.0025	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00246	0.00249	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00231	0.00234	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00225	0.00228	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00225	0.00228	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00224	0.00227	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00218	0.00221	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00214	0.00217	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00214	0.00217	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00209	0.00212	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00208	0.00211	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—NOS2—abdominal aortic aneurysm	0.00205	0.00208	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00204	0.00206	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00203	0.00206	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00203	0.00205	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00198	0.00201	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—MMP9—abdominal aortic aneurysm	0.00197	0.00199	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00195	0.00197	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—MMP9—abdominal aortic aneurysm	0.00192	0.00194	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.0019	0.00192	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00187	0.0019	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP2—abdominal aortic aneurysm	0.00187	0.00189	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP2—abdominal aortic aneurysm	0.00182	0.00185	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00176	0.00178	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—SERPINE1—abdominal aortic aneurysm	0.00173	0.00175	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00172	0.00174	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00171	0.00174	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00171	0.00173	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00163	0.00166	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00162	0.00164	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.0016	0.00163	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00158	0.00161	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00158	0.00161	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00158	0.0016	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00156	0.00158	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00154	0.00156	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00151	0.00153	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.0015	0.00153	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00146	0.00148	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00144	0.00146	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00142	0.00144	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.0014	0.00142	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.00139	0.00141	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00139	0.00141	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP9—abdominal aortic aneurysm	0.00137	0.00139	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00137	0.00139	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.00135	0.00137	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00133	0.00134	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00131	0.00133	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.0013	0.00132	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.0013	0.00132	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00127	0.00129	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.00125	0.00126	CbGpPWpGaD
Ketamine—TACR1—connective tissue—abdominal aortic aneurysm	0.00124	0.0921	CbGeAlD
Ketamine—OPRD1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00123	0.00124	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00122	0.00123	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00121	0.00122	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.0012	0.00122	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.0012	0.00122	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00115	0.00117	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00115	0.00117	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00115	0.00116	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00113	0.00114	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00112	0.00114	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.0011	0.00111	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00107	0.00109	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.00107	0.00109	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00107	0.00108	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00106	0.00107	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00105	0.00107	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AAAS—abdominal aortic aneurysm	0.00104	0.00105	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00103	0.00104	CbGpPWpGaD
Ketamine—GRIN2D—spinal cord—abdominal aortic aneurysm	0.00101	0.0749	CbGeAlD
Ketamine—OPRK1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00101	0.00102	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000988	0.001	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000972	0.000986	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000964	0.000977	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000962	0.000975	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000947	0.00096	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000921	0.000933	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000908	0.000921	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000908	0.000921	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—LDLR—abdominal aortic aneurysm	0.000906	0.000918	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000903	0.000916	CbGpPWpGaD
Ketamine—GRIN1—spinal cord—abdominal aortic aneurysm	0.000902	0.0667	CbGeAlD
Ketamine—OPRM1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000895	0.000907	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000884	0.000896	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000875	0.000887	CbGpPWpGaD
Ketamine—OPRD1—kidney—abdominal aortic aneurysm	0.00086	0.0637	CbGeAlD
Ketamine—GRIN2B—spinal cord—abdominal aortic aneurysm	0.00086	0.0637	CbGeAlD
Ketamine—OPRM1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00085	0.000861	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00085	0.000861	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000844	0.000856	CbGpPWpGaD
Ketamine—PTGS1—artery—abdominal aortic aneurysm	0.000842	0.0623	CbGeAlD
Ketamine—TACR1—spinal cord—abdominal aortic aneurysm	0.000825	0.061	CbGeAlD
Ketamine—OPRD1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000821	0.000832	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000813	0.000824	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000807	0.000818	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000792	0.000803	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AAAS—abdominal aortic aneurysm	0.000792	0.000802	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00078	0.000791	CbGpPWpGaD
Ketamine—CYP2C8—blood plasma—abdominal aortic aneurysm	0.000779	0.0576	CbGeAlD
Ketamine—GRIN2A—spinal cord—abdominal aortic aneurysm	0.000752	0.0556	CbGeAlD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000722	0.000731	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00072	0.000729	CbGpPWpGaD
Ketamine—CYP2B6—blood plasma—abdominal aortic aneurysm	0.000699	0.0517	CbGeAlD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000694	0.000704	CbGpPWpGaD
Ketamine—CYP2C9—blood plasma—abdominal aortic aneurysm	0.000692	0.0512	CbGeAlD
Ketamine—CYP2B6—Metabolism—LDLR—abdominal aortic aneurysm	0.000691	0.0007	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000688	0.000698	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000682	0.000692	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00068	0.00069	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000678	0.000688	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000677	0.000687	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00067	0.000679	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	0.00067	0.000679	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000669	0.000679	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000648	0.000657	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000644	0.000653	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000635	0.000643	CbGpPWpGaD
Ketamine—PTGS1—blood plasma—abdominal aortic aneurysm	0.000632	0.0467	CbGeAlD
Ketamine—DRD2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000616	0.000624	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000608	0.000616	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	0.000585	0.000593	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000584	0.000592	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000568	0.000576	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000565	0.000573	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000557	0.000564	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000554	0.000561	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	0.000545	0.000553	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000534	0.000541	CbGpPWpGaD
Ketamine—CYP3A4—blood plasma—abdominal aortic aneurysm	0.000528	0.039	CbGeAlD
Ketamine—DRD2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000517	0.000524	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	0.00051	0.000517	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000507	0.000514	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000498	0.000505	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00048	0.000487	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AGT—abdominal aortic aneurysm	0.000479	0.000485	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	0.000476	0.000483	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00047	0.000477	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—APOE—abdominal aortic aneurysm	0.000469	0.000475	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000468	0.000474	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000466	0.000472	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000461	0.000467	CbGpPWpGaD
Ketamine—OPRM1—spinal cord—abdominal aortic aneurysm	0.000457	0.0338	CbGeAlD
Ketamine—OPRK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000437	0.000443	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000395	0.000401	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000382	0.000387	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000379	0.000385	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000377	0.000383	CbGpPWpGaD
Ketamine—ABCB1—blood plasma—abdominal aortic aneurysm	0.000373	0.0276	CbGeAlD
Ketamine—OPRM1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000369	0.000374	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AGT—abdominal aortic aneurysm	0.000365	0.00037	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000364	0.000369	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	0.00036	0.000365	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—APOE—abdominal aortic aneurysm	0.000358	0.000363	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000357	0.000361	CbGpPWpGaD
Ketamine—CYP2C8—kidney—abdominal aortic aneurysm	0.000353	0.0261	CbGeAlD
Ketamine—PTGS1—connective tissue—abdominal aortic aneurysm	0.000336	0.0249	CbGeAlD
Ketamine—OPRK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000335	0.000339	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000331	0.000336	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000321	0.000326	CbGpPWpGaD
Ketamine—CYP2B6—kidney—abdominal aortic aneurysm	0.000317	0.0234	CbGeAlD
Ketamine—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	0.000314	0.000318	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	0.000309	0.000313	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	0.000303	0.000307	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.0003	0.000304	CbGpPWpGaD
Ketamine—PTGS1—kidney—abdominal aortic aneurysm	0.000286	0.0212	CbGeAlD
Ketamine—OPRM1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000283	0.000287	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00028	0.000284	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00028	0.000284	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	0.000269	0.000273	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	0.000264	0.000268	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	0.000252	0.000255	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	0.000247	0.00025	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—abdominal aortic aneurysm	0.000245	0.000249	CbGpPWpGaD
Ketamine—CYP3A4—kidney—abdominal aortic aneurysm	0.000239	0.0177	CbGeAlD
Ketamine—PTGS1—spinal cord—abdominal aortic aneurysm	0.000223	0.0165	CbGeAlD
Ketamine—DRD2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000214	0.000217	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000212	0.000215	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	0.000208	0.00021	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000181	0.000183	CbGpPWpGaD
Ketamine—ABCB1—kidney—abdominal aortic aneurysm	0.000169	0.0125	CbGeAlD
Ketamine—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	0.000169	0.000171	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	0.000166	0.000168	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	0.000163	0.000165	CbGpPWpGaD
Ketamine—ABCB1—spinal cord—abdominal aortic aneurysm	0.000132	0.00975	CbGeAlD
Ketamine—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	0.000111	0.000113	CbGpPWpGaD
